BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36559313)

  • 1. Recent Advancements in Drug Delivery of Sinomenine, A Disease-Modifying Anti-Rheumatic Drug.
    Chen X; Lu C; Duan Y; Huang Y
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional nanoparticles of sinomenine hydrochloride for treat-to-target therapy of rheumatoid arthritis via modulation of proinflammatory cytokines.
    Lin Y; Yi O; Hu M; Hu S; Su Z; Liao J; Wang W; Wang S; Liu L; Liu B; Cai X
    J Control Release; 2022 Aug; 348():42-56. PubMed ID: 35569587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum.
    Yamasaki H
    Acta Med Okayama; 1976 Feb; 30(1):1-20. PubMed ID: 61710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on pharmacokinetics of sinomenine and its anti-inflammatory and immunomodulatory effects.
    Wang S; Zhang L; Zhou Y; Liu Z; Zhou Z; Huang J
    Int Immunopharmacol; 2023 Jun; 119():110227. PubMed ID: 37119677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-amorphous systems of sinomenine with nonsteroidal anti-inflammatory drugs: A strategy for solubility improvement, sustained release, and drug combination therapy against rheumatoid arthritis.
    Chen X; Li D; Zhang H; Duan Y; Huang Y
    Int J Pharm; 2021 Sep; 606():120894. PubMed ID: 34280485
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ding C; Li Y; Sun Y; Wu Y; Wang F; Liu C; Zhang H; Jiang Y; Zhang D; Song X
    Am J Chin Med; 2022; 50(5):1219-1253. PubMed ID: 35681262
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal toxic epidermal necrolysis associated with sinomenine in a patient with primary membranous nephropathy.
    Li XX; Zhang JT; Ding XY
    Clin Nephrol Case Stud; 2023; 11():126-131. PubMed ID: 37575312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinomenine-phenolic acid coamorphous drug systems: Solubilization, sustained release, and improved physical stability.
    Chen X; Li D; Zhang H; Duan Y; Huang Y
    Int J Pharm; 2021 Apr; 598():120389. PubMed ID: 33609724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinomenine hydrochloride protects against polymicrobial sepsis via autophagy.
    Jiang Y; Gao M; Wang W; Lang Y; Tong Z; Wang K; Zhang H; Chen G; Liu M; Yao Y; Xiao X
    Int J Mol Sci; 2015 Jan; 16(2):2559-73. PubMed ID: 25625512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyvinylpyrrolidone microneedles for localized delivery of sinomenine hydrochloride: preparation, release behavior of
    Shu Z; Cao Y; Tao Y; Liang X; Wang F; Li Z; Li Z; Gui S
    Drug Deliv; 2020 Dec; 27(1):642-651. PubMed ID: 32329377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinomenine, an Alkaloid Derived from
    Yoo JH; Ha TW; Hong JT; Oh KW
    Biomol Ther (Seoul); 2017 Nov; 25(6):586-592. PubMed ID: 29081090
    [No Abstract]   [Full Text] [Related]  

  • 12. Sex-related differences in safety profiles, pharmacokinetics and tissue distribution of sinomenine hydrochloride in rats.
    Huang H; Zhang EB; Yi OY; Wu H; Deng G; Huang YM; Liu WL; Yan JY; Cai X
    Arch Toxicol; 2022 Dec; 96(12):3245-3255. PubMed ID: 36040703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro.
    Jiang T; Zhou L; Zhang W; Qu D; Xu X; Yang Y; Li S
    Mol Med Rep; 2010; 3(1):51-6. PubMed ID: 21472199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sinomenine potentiates degranulation of RBL-2H3 basophils via up-regulation of phospholipase A2 phosphorylation by Annexin A1 cleavage and ERK phosphorylation without influencing on calcium mobilization.
    Huang L; Li T; Zhou H; Qiu P; Wu J; Liu L
    Int Immunopharmacol; 2015 Oct; 28(2):945-51. PubMed ID: 25939534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinomenine hydrochloride ameliorates dextran sulfate sodium-induced colitis in mice by modulating the gut microbiota composition whilst suppressing the activation of the NLRP3 inflammasome.
    Zhou Y; Chen S; Gu W; Sun X; Wang L; Tang L
    Exp Ther Med; 2021 Nov; 22(5):1287. PubMed ID: 34630642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Th1 and Th2 immune responses in mice by Sinomenine, an alkaloid extracted from the chinese medicinal plant Sinomenium acutum.
    Feng H; Yamaki K; Takano H; Inoue K; Yanagisawa R; Yoshino S
    Planta Med; 2006 Dec; 72(15):1383-8. PubMed ID: 17091433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of novel sinomenine derivatives.
    Zhao Z; Xiao J; Wang J; Dong W; Peng Z; An D
    Int Immunopharmacol; 2015 Dec; 29(2):354-360. PubMed ID: 26525983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of novel sinomenine microcapsules for oral controlled drug delivery.
    Shi D; Greever R; Chen Y
    Drug Dev Ind Pharm; 2010 Apr; 36(4):482-9. PubMed ID: 19877829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of macrophage migration by down-regulating Src/FAK/P130Cas activation contributed to the anti-inflammatory activity of sinomenine.
    Gao WJ; Liu JX; Xie Y; Luo P; Liu ZQ; Liu L; Zhou H
    Pharmacol Res; 2021 May; 167():105513. PubMed ID: 33617975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of sinomenine/8-Bis(benzylthio)octanoic acid hybrids as potential anti-leukemia drug candidate via mitochondrial pathway.
    Gao X; Li H; Wang S; Long X; Guo X; Hua H; Li D
    Bioorg Med Chem Lett; 2024 Jan; 97():129545. PubMed ID: 37939862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.